Indian drug firms cheer dexamethasone efficacy on severe COVID-19 patients

M P Gupta, general manager of Mahima Lifesciences, a Chandigarh-based steroid API maker, said the company was expecting a jump in raw material costs and possible supply disruption if demand goes up.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news